3 companies in GreatPoint Ventures's investment portfolio.
Back to GreatPoint Ventures profile“Invests in early-stage healthcare and life sciences companies developing innovative technologies and therapeutics.”
A biopharmaceutical company focused on developing and commercializing therapies for rare and underserved diseases, particularly in ophthalmology.
Clinical-stage biopharmaceutical company developing treatments for rare endocrine diseases and hormonal disorders, ceased operations in 2021.
Biopharmaceutical company developing novel antibiotics to treat antibiotic-resistant bacterial infections.
GreatPoint Ventures has built a portfolio of 3 companies across 1 sector, including Biotech.
The portfolio reflects investments across the IPO stage, showing GreatPoint Ventures's approach to supporting companies at a focused stage of development.
GreatPoint Ventures has invested in 3+ companies across 1 different sectors.
GreatPoint Ventures's portfolio spans Biotech. This diversification reflects the firm's broad investment thesis and sector expertise.
GreatPoint Ventures invests across the IPO stage. Their portfolio includes companies at various points in their growth journey.
Archstone
Fund admin, LP portal, capital calls, distributions, and reporting in one place. Purpose-built for emerging fund managers. Starting at $297/mo.
See Archstone